News

National Office establishes new research ethics committee for the National Irish COVID-19 Biobank

National Office establishes new research ethics committee for the National Irish COVID-19 Biobank

The National Irish COVID-19 Biobank (NICB) is a health research infrastructure that collects and stores biological samples and associated health data, with the aim of supporting Ireland’s research response to COVID-19. To ensure its operation is underpinned by robust ethical standards, the Department of Health has tasked the National Office for Research Ethics Committees with […]

National Office establishes new research ethics committee for the National Irish COVID-19 Biobank Read More »

Photograph of a scientist looking in a microscope

NREC-MD expands remit to include review of in vitro medical devices

As the new EU In Vitro Medical Devices Regulation comes into effect on 26 May following a five-year transition period, the National Office for Research Ethics Committees is pleased to announce that the National Research Ethics Committee for Medical Devices (NREC-MD) will now expand its remit to review applications seeking ethical approval for performance studies

NREC-MD expands remit to include review of in vitro medical devices Read More »

New Clinical Trial Regulation: Minister Donnelly pays tribute to NREC committee members

In this video, Minister Stephen Donnelly reflects on why the introduction of new EU clinical trial regulation marks an important milestone in the advancement of Irish health research, and pays tribute to the pivotal role of the National Office for Research Ethics Committees (NRECs) volunteer committee members in championing better health and care for all.   Having entered into

New Clinical Trial Regulation: Minister Donnelly pays tribute to NREC committee members Read More »

Status of assessment of clinical trial substantial amendments

Applicants should note that the NREC-CT is experiencing a very high number of substantial amendment submissions. Your patience is appreciated while the National Office team and the committees work at capacity to process these. Please note the team cannot correspond on the status of individual submissions. Our parent department, the Department of Health is fully

Status of assessment of clinical trial substantial amendments Read More »

Scroll to Top